---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-095765"
form_type: "8-K"
ticker: "ALUR"
cik: "0001964979"
company_name: "ALLURION TECHNOLOGIES, INC."
filed_at: "2024-08-13T23:59:59+00:00"
generated_at: "2026-05-31T09:51:59.569120+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Allurion Q2 revenue $11.8M, sequential +25%; French regulator suspends Balloon sales; FY guidance lowered to $40-45M

## Summary
- Q2 2024 revenue $11.8M, up 25% sequentially from Q1 but down from $13M in Q2 2023.
- Operating loss improved to $9.3M from $13.3M in Q2 2023; record procedure volume >10,000 balloon placements for second straight quarter.
- ANSM (French regulator) suspended Allurion Balloon sales; company withdrawing from France pending remediation plan on advertising and patient follow-up.
- Full-year 2024 revenue guidance reduced to $40-45M from prior; procedure volume growth expected 10-15%.
- Cash $19.3M at June 30; completed public offering in July 2024 for ~$22M gross proceeds.

## SEC filing metadata
- accession: 0000950170-24-095765
- form_type: 8-K
- ticker: ALUR
- cik: 0001964979
- company_name: ALLURION TECHNOLOGIES, INC.
- filed_at: 2024-08-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1964979/000095017024095765/0000950170-24-095765-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1964979/000095017024095765/alur-20240813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-095765
- JSON: https://secwatch.observer/filing/0000950170-24-095765.json
- Plain text: https://secwatch.observer/filing/0000950170-24-095765.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.